Evidence map›Paper›PMID 28762874›Full record

ArticleEpigenetics2017

Reactivation of hyperglycemia-induced hypocretin (HCRT) gene silencing by N-acetyl-d-mannosamine in the orexin neurons derived from human iPS cells.

Koji Hayakawa, Yasuharu Sakamoto, Osamu Kanie, Atsuko Ohtake, Shusaku Daikoku, Yukishige Ito, Kunio Shiota

Open access · bronzeAbstract read
In one paragraph

Article in Epigenetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Involvement of PLAGL1/ZAC1 in hypocretin/orexin transcription.International journal of molecular medicine · 2019
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Koji Hayakawaa Laboratory of Cellular Biochemistry, Department of Animal Resource Sciences/Veterinary Medical Sciences , The University of Tokyo , Tokyo , Japan.ORCID 0000-0003-0453-1303
Yasuharu Sakamotob Synthetic Cellular Chemistry Laboratory , RIKEN , 2-1 Hirosawa, Wako , Saitama , Japan.
Osamu Kaniec Japan Science and Technology Agency ERATO Glycotrilogy Project , 2-1 Hirosawa, Wako , Saitama , Japan.ORCID 0000-0003-4147-6868
Atsuko Ohtakec Japan Science and Technology Agency ERATO Glycotrilogy Project , 2-1 Hirosawa, Wako , Saitama , Japan.
Shusaku Daikokuc Japan Science and Technology Agency ERATO Glycotrilogy Project , 2-1 Hirosawa, Wako , Saitama , Japan.
Yukishige Itob Synthetic Cellular Chemistry Laboratory , RIKEN , 2-1 Hirosawa, Wako , Saitama , Japan.ORCID 0000-0001-6251-7249
Kunio Shiotaa Laboratory of Cellular Biochemistry, Department of Animal Resource Sciences/Veterinary Medical Sciences , The University of Tokyo , Tokyo , Japan.
Japan Science and Technology Agency · JPRIKEN Advanced Science Institute · JPThe University of Tokyo · JPTokai University · JPWaseda University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Orexin neurons regulate critical brain activities for controlling sleep, eating, emotions, and metabolism, and impaired orexin neuron function results in several neurologic disorders. Therefore, restoring normal orexin function and understanding the mechanisms of loss or impairment of orexin neurons represent important goals. As a step toward that end, we generated human orexin neurons from induced pluripotent stem cells (hiPSCs) by treatment with N-acetyl-d-mannosamine (ManNAc) and its derivatives. The generation of orexin neurons was associated with DNA hypomethylation, histone H3/H4 hyperacetylation, and hypo-O-GlcNAcylation on the HCRT gene locus, and, thereby, the treatment of inhibitors of SIRT1 and OGT were effective at inducing orexin neurons from hiPSCs. The prolonged exposure of orexin neurons to high glucose in culture caused irreversible silencing of the HCRT gene, which was characterized by H3/H4 hypoacetylation and hyper-O-GlcNAcylation. The DNA hypomethylation status, once established in orexin neurogenesis, was maintained in the HCRT-silenced orexin neurons, indicating that histone modifications, but not DNA methylation, were responsible for the HCRT silencing. Thus, the epigenetic status of the HCRT gene is unique to the hyperglycemia-induced silencing. Intriguingly, treatment of ManNAc and its derivatives reactivated HCRT gene expression, while inhibitors SIRT1 and the OGT did not. The present study revealed that the HCRT gene was silenced by the hyperglycemia condition, and ManNAc and its derivatives were useful for restoring the orexin neurons.

Indexed as

AcetylationDNA MethylationEpigenesis, GeneticGene SilencingHexosaminesHistonesHumansHyperglycemiaInduced Pluripotent Stem CellsNeuronsOrexinsHCRT protein, humanHexosaminesHistonesN-acetylmannosamineOrexinsHistone acetylationhyperglycemianeurodegenerationO-GlcNAcylationorexin

Identifiers

PMID28762874
PMCPMC5739098
OpenAlexW2741084030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.